Loading...
Loading...
Relypsa, Inc.
RLYP, a biopharmaceutical company, today announced that on October
1, 2015, the compensation committee of the company's board of directors
granted four new employees options to purchase an aggregate of 5,750 shares
of the company's common stock with a per share exercise price of $18.54, the
closing trading price on the grant date, and 2,875 restricted stock units.
The stock options and restricted stock units were granted pursuant to the
Relypsa, Inc. 2014 Employment Commencement Incentive Plan, which was
approved by the company's board of directors in June 2014 under Rule
5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce
new employees to enter into employment with the company.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in